BACKGROUND: We performed a prospective, randomized, controlled trial to compare the quality, hemodynamic response, and recovery index of laryngeal mask airway (LMA) insertion after either propofol alone or co-administration of alfentanil-propofol anesthesia. METHODS: Sixty patients (ASA 1 or 2, 17-63 years) were randomly allocated to control and experimental group. Control group(Group I) was received placebo (saline), experimental groups were received alfentanil 10microgram/kg (Group II), 20microgram/kg (Group III), 30microgram/kg (Group IV). RESULTS: Loss of consciousness and LMA insertion were more rapid in patients with alfentanil 30 microgram/kg group than control group (P<0.05). In alfentanil 20microgram/kg group, loss of consciousness was more rapid than control group. Also, there were significant differences in propofol induction dose, effect site concentration on induction, and propofol maintenance dose between control and experimental group (P<0.05). CONCLUSIONS: We conclude that co-adminstration of alfentanil-propofol, especially 30microgram/kg group, compares favorably with propofol alone, although LMA removal time is prolonged.
Alfentanil ; Anesthesia ; Hemodynamics ; Humans ; Laryngeal Masks* ; Propofol* ; Prospective Studies ; Unconsciousness

BACKGROUND: Alfentanil has been shown to act synergistically if combined with propofol, with or without nitrous oxide, or if combined with potent inhalation anesthetics. The goal of this study was to determine the dosing rate and target plasma concentration of propofol to supplement nitrous oxide in the presence of varying concentrations of alfentanil and to determine the optimal combination of propofol and alfentanil. METHODS: Sixty patients undergoing a total abdominal hysterectomy (TAH) were anesthetized with nitrous oxide, and given a target-controlled infusion (TCI) of alfentanil [target plasma concentrations of 0 (A0 group), 50 ng/ml (A50 group), and 100 ng/ml (A100 group)], and propofol at rates varied up and down depending on the bispectal index (BIS). The mean target concentration (Tc) and infusion rate of propofol according to changes of concentrations of alfentanil were determined. Recovery time (from infusion stop to eye opening) and side effects were compared. RESULTS: Induction time and recovery time were shortened in the A50 group and A100 group compared with the A0 group (P < 0.05). The infusion rate and mean target concentration of propofol were significantly lower in the A100 group (7.5 mg/kg/h, 3.4ng/ml) than the A0 (12.6 mg/kg/h, 4.5ng/ml) and A50 (10.2 mg/kg/h, 4.0ng/ml) groups (P < 0.01). Side effects did not differ among the three groups. CONCLUSIONS: The optimal blood propofol and plasma alfentanil concentration, with respect to satisfactory intraoperative anesthetic conditions and speed of recovery, are 4.0ng/ml and 50 ng/ml or 3.4ng/ ml and 100 ng/ml in TAH patients.
Alfentanil* ; Anesthetics, Inhalation ; Humans ; Hysterectomy* ; Nitrous Oxide ; Plasma ; Propofol*

BACKGROUND: Intraoperative alfentanil is known to increase the epileptic discharge in the adult seizure patients. This study hypothesized that alfentanil might localize an epileptogenic focus in pediatric seizure patients. METHODS: This study was performed in the pediatric seizure patients who undergo second-staged operation. Thirteen pediatric patients were enrolled and their epileptic foci were already suspected from first operation. After anesthetic induction, sevoflurane was maintained at 0.6% end-tidal concentration for study period. Electrocorticography (ECoG) was recorded for 5 minutes before and 5 minutes after alfentanil 20microgram/kg IV. During the ECoG recordings, the mean arterial pressure (MAP) and heart rate (HR) were continuously monitored. After the surgery, a pediatric neurologist analyzed the changes of spike frequencies of suspected ictal zone. The spike frequencies of suspected non-ictal zone were also calculated in five patients. The suspected ictal zone was defined as the most abundant spontaneous spiking area observed after first staged grid insertion. RESULTS: Alfentanil induced a significant increase in spike activity of suspected ictal zone in 12 out of 13 patients (median of 20 [ranged 10 to 100] vs 38 [ranged 20 to 100], P< 0.05). Alfentanil-induced increase of spike activity was prominent in the suspected ictal zone rather than non-ictal zone. There were no significant changes in the MAP and HR after administration of alfentanil. CONCLUSIONS: Alfentanil activates epileptiform activity of suspected ictal zone in pediatric patients with seizure disorder and can be used to assist in the localization of the epileptogenic focus during seizure surgery.
Adult ; Alfentanil* ; Arterial Pressure ; Epilepsy* ; Heart Rate ; Humans ; Seizures*

BACKGROUND: The administration of short-acting opioids before emergence is useful for preventing emergence cough induced by an endotracheal tube. This study examined the clinically effective dose of alfentanil for suppressing cough during emergence from desflurane anesthesia. METHODS: Twenty-nine adult patients undergoing elective oral surgery were enrolled in this study. During emergence from anesthesia, the patients received alfentanil diluted in 10 ml normal saline when the end-tidal vol% of desflurane decreased to 3%. The initial alfentanil dose was 16 microg/kg. The alfentanil dose for consecutive patients, determined by Dixon's up-and-down method, increased or decreased by 2 microg/kg according to a previous patient's result. RESULTS: The 50% effective dose (ED50) of alfentanil for suppressing cough during emergence from desflurane anaesthesia was 9.3 +/- 1.5 microg/kg according to Dixon's up-and-down method. Isotonic regression revealed an ED50 and ED95 (95% confidence interval) of alfentanil 10.0 microg/kg (6.8-13.2 microg/kg) and 14.0 microg/kg (7.7-19.4 microg/kg), respectively. CONCLUSIONS: The ED95 of alfentanil for suppressing emergence cough was 14.0 microg/kg. A single bolus administration of alfentanil during emergence from anesthesia was useful for suppressing emergence cough.
Adult ; Alfentanil ; Analgesics, Opioid ; Anesthesia ; Cough ; Humans ; Isoflurane ; Surgery, Oral

BACKGROUND: The aim of this randomized double-blinded study was to determine the optimal concentration of alfentanil with 0.15% ropivacaine for postoperative patient-controlled epidural analgesia. METHODS: Forty five patients undergoing major abdominal surgery under general anesthesia were assigned to groups receiving patient-controlled thoracic epidural analgesia with 0.15% ropivacaine + 45 microgram/ml alfentanil (Group I), 75microgram/ml alfentanil (Group II), 150 microgram/ml alfentanil (Group III). The incidence of side effects and additional analgesic use, VAS (visual analog pain scale) on resting and coughing, and patient's satisfaction were checked for 24 hours after a loading dose injection. RESULTS: The VAS on coughing and resting 1 hour after the loading dose injection were significantly lower in Groups II and III than in Group I. The patients in group II were more satisfied with the result than those in Group I. CONCLUSIONS: A combination of 0.15% ropivacaine and 75microgram/ml alfentanil for thoracic epidural analgesia after major abdominal surgery provides the best analgesia with minimal side effects and a higher level of patient's satisfaction.
Alfentanil* ; Analgesia ; Analgesia, Epidural* ; Anesthesia, General ; Cough ; Humans ; Incidence

BACKGROUND: The lower levels of cardiotoxicity and motor block make ropivacaine well suited as an epidural infusion for postoperative analgesia. This study examined the analgesic efficacy of an epidural infusion of ropivacaine alone and in combination with alfentanil after major abdominal surgery. METHODS: Thirty patients undergoing major abdominal surgery under general anesthesia were divided into two groups receiving patient-controlled thoracic epidural analgesia with 0.2% ropivacaine (Group I) and 0.15% ropivacaine +150 microgram/ml alfentanil (Group II). The motor block, side effects, VAS (visual analog pain scale) score on coughing and resting, additional analgesics use, and patient's satisfaction were checked for 24 hours after a loading dose injection. RESULTS: The VAS score in group II was significantly lower than in group I, and the patients in group II were more satisfied than those in group I (P < 0.05). However, there were more side effects in group II. CONCLUSIONS: Postoperative epidural infusion of 0.15% ropivacaine with 150 microgram/ml alfentanil is more effective than 0.2% ropivacaine only.
Alfentanil* ; Analgesia* ; Analgesia, Epidural ; Analgesics ; Anesthesia, General ; Cough ; Humans

BACKGROUND: Nitrous oxide may cause distension of the intestine. We studied the influence of nitrous oxide on the recovery of bowel function and the incidence of complications of bowel distension. METHODS: Fifty patients scheduled for abdominal hysterectomy were anesthetized with sevoflurane and oxygen and were randomly assigned to be given 50% nitrous oxide (n = 25) or 50% air (n = 25) in two groups. A surgeon assessed the closing condition. Patients reported pain, nausea and vomiting after surgery. The lapse of time before the passing of flatus was recorded. RESULTS: There was no difference between the two groups with respect to body weight, duration of surgery, alfentanil and atracurium requirements, pain score, nausea and vomiting, and closing condition. The time elapsing before the passing of flatus was significantly greater for the patients that received nitrous oxide. CONCLUSIONS: Our results suggest that avoiding nitrous oxide administration during prolonged intraabdominal surgery shortens the time for recovery of bowel function.
Alfentanil ; Atracurium ; Body Weight ; Flatulence ; Humans ; Hysterectomy ; Incidence ; Intestines ; Nausea ; Nitrous Oxide* ; Oxygen ; Recovery of Function* ; Vomiting

BACKGROUND: Endotracheal fiberoptic bronchoscope intubation causes significant hemodynamic changes such as hypertension and tachycardia. The aim of this study was to evaluate the effects of alfentanil on cardiovascular response to endotracheal fiberoptic bronchoscope intubation in the patients anesthetized with N2O-O2-enflurane. METHODS: Forty seven healthy patients undergoing elective surgery requiring orotracheal intubation were randomly allocated to three groups and received either normal saline (control group), 8microgram/kg alfentanil (ALF8 group), or 4microgram/kg alfentanil (ALF4 group). Orotracheal intubation using a fiberoptic bronchoscope was carried out. Systolic, diastolic, and mean arterial blood pressures, and heart rates were monitored noninvasively and recorded at one-minute intervals. RESULTS: The percent change in mean arterial blood pressure from preanesthetic mean arterial blood pressure, was attenuated (P < 0.05 compared with the control group) in the ALF8 group 1 minute after intubation, but percent changes in mean arterial blood pressures from preanesthetic mean arterial blood pressure levels did not alter in the ALF4 or ALF8 groups between 1 and 5 minutes after intubation. Percent changes in heart rates from preanesthetic heart rates did not in either the ALF4 or ALF8 groups during the 5 minutes following intubation. CONCLUSIONS: These results show that alfentanil (8microgram/kg) attenuates blood pressure response to fiberoptic bronchoscopic intubation in patients anesthetized with N2O-O2-enflurane, but that it does not influence heart rate response.
Alfentanil ; Arterial Pressure ; Blood Pressure ; Bronchoscopes ; Heart Rate ; Hemodynamics ; Humans ; Hypertension ; Intubation ; Intubation, Intratracheal* ; Tachycardia

BACKGROUND: This study was conducted to compare the efficacy of intravenous alfentanil and lidocaine as a pretreatment for the prevention of withdrawal movements following a rocuronium injection and hemodynamic change following tracheal intubation. METHODS: This study evaluated 180 patients that were divided into the following 3 pretreatment groups: group C: normal saline, group L: lidocaine 1 mg/kg, group A: alfentanil 10microgram/kg. Anesthesia was induced using 5 mg/kg thiopental sodium, after which the test drug was injected. Rocuronium (1 mg/kg) was then administered 1 minute after the test drug was injected over 5 seconds and the response was characterized as one of the following: no movement, movement limited to the wrist, to the elbow or to the shoulder. Intubation was performed 1 minute later. Systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR) were then recorded at each of the following points: T1: preinduction, T2: immediately prior to rocuronium injection, T3: immediately after rocuronium injection, T4: immediately prior to intubation, T5: immediately after intubation, T6: 1 minute after intubation, T7: 5 minutes after intubation. RESULTS: The incidence of withdrawal movement was significantly lower in group A than groups C and L (P < 0.05). In addition, SBP, DBP and HR following intubation were significantly lower in group A than group C and group L (P < 0.05). CONCLUSIONS: Pretreatment with 10microgram/kg of alfentanil effectively reduced the incidence of withdrawal movement in response of rocuronium injection and caused minimal hemodynamic changes following intubation.
Alfentanil ; Androstanols ; Anesthesia ; Blood Pressure ; Elbow ; Heart Rate ; Hemodynamics ; Humans ; Incidence ; Intubation ; Lidocaine ; Shoulder ; Thiopental ; Wrist

BACKGROUND: Because desflurane can cause airway irritability when used to induce anesthesia, drugs aimed at reducing airway irritability. This study investigated the possible differences between lidocaine and alfentanil on the decrease in the airway irritability during desflurane inhaled induction. METHODS: 75 patients (25 in each groups) were assigned randomly to induce anesthesia with inhaled desflurane. The breathing circuit was primed with desflurane 6% in 50% O2 and 50% N2O. After pretreatment with 2% lidocaine (1 mg/kg), or alfentanil (10microgram/kg), or saline (7 ml) intravenously 2 minutes before inducing anesthesia, each patient breathed the gas mixture through a tight fitting facemask. The time to loss of consciousness, cough, laryngospasm, excitatory movement and hemodynamics were checked before and after inhalation. RESULTS: The time to loss of consciousness, cough and excitatory movement were lower significantly between in the control group and other groups, but there was no difference between the 2% lidocaine and alfentanil groups. The blood pressure and heart rate were lower in the alfentanil group, but the heart rate was similar. CONCLUSIONS: These results explain that intravenous 2% lidocaine appears to be useful. However, Intravenous alfentanil can also reduce the airway irritability and stabilize the hemodynamics significantly when desflurane is used to induce anesthesia.
Alfentanil* ; Anesthesia ; Blood Pressure ; Cough ; Heart Rate ; Hemodynamics* ; Humans ; Inhalation ; Laryngismus ; Lidocaine* ; Respiration ; Unconsciousness